Tony Ho, Head of Research and Development at CRISPR Therapeutics, offers his insights into the advantages of CRISPR gene editing over other technologies and what...
Effective therapies for neurodegenerative diseases like Alzheimer's are urgently needed. But developing new drugs is difficult, time-consuming, and expensive, w...